Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Fish and Richardson
Fuji
Federal Trade Commission
Express Scripts
Johnson and Johnson
Chinese Patent Office
Dow
Harvard Business School
Citi

Generated: January 16, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,661,136

« Back to Dashboard

Which drugs does patent 5,661,136 protect, and when does it expire?

Patent 5,661,136 protects CLOLAR and is included in one NDA.

Protection for CLOLAR has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has fifteen patent family members in ten countries.
Summary for Patent: 5,661,136
Title: 2-halo-2'-fluoro ARA adenosines as antinoplastic agents
Abstract:The present invention is directed to certain 2'-fluoro, 2-substituted purine nucleosides which are toxic to cancerous cell lines.
Inventor(s): Montgomery; John A. (Birmingham, AL), Secrist, III; John A. (Birmingham, AL)
Assignee: Southern Research Institute (Birmingham, AL)
Application Number:08/320,879
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 5,661,136

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Genzyme CLOLAR clofarabine INJECTABLE;IV (INFUSION) 021673-001 Dec 28, 2004 AP RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 5,661,136

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
5,034,518 2-fluoro-9-(2-deoxy-2-fluoro-.beta.-D-arabinofuranosyl) adenine nucleosides ➤ Subscribe
5,384,310 2'-fluoro-2-haloarabinoadinosines and their pharmaceutical compositions ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,661,136

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 147751 ➤ Subscribe
Australia 5831590 ➤ Subscribe
Canada 2102782 ➤ Subscribe
Germany 122006000060 ➤ Subscribe
Germany 69029733 ➤ Subscribe
European Patent Office 0473708 ➤ Subscribe 300247 Netherlands ➤ Subscribe
European Patent Office 0473708 ➤ Subscribe 06C0038 France ➤ Subscribe
European Patent Office 0473708 ➤ Subscribe SPC/GB06/040 United Kingdom ➤ Subscribe
European Patent Office 0595826 ➤ Subscribe
Spain 2098266 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
UBS
Johnson and Johnson
Citi
Cerilliant
Moodys
Novartis
QuintilesIMS
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot